Metastases to hemangioblastomas in von Hippel-Lindau disease

S. Taylor Jarrell, Alexander Vortmeyer, W. Marston Linehan, Edward H. Oldfield, Russell R. Lonser

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Object. Patients with hereditary cancer syndromes may be at increased risk for the development of tumor-to-tumor metastases. To gain insight into the biological nature of these lesions in the central nervous system (CNS), to determine their prevalence in a familial neoplasia syndrome, and to better define their management, the authors retrospectively examined a series of cases in which metastatic lesions developed within hemangioblastomas in patients with von Hippel-Lindau (VHL) disease. Methods. The study included all cases of VHL disease in which patients underwent resection of a CNS hemangioblastoma that contained a metastasis or were found at autopsy to have a metastasis to a hemangioblastoma between January 2002 and December 2005 at the National Institute of Neurological Disorders and Stroke (NINDS). Clinical, histopathological, imaging, and surgical and/or autopsy findings were analyzed. Metastasis to a CNS hemangioblastoma was found in six resected tumors (8% of all hemangioblastomas resected from patients with VHL disease at the NINDS during the study period) from six patients (five women, one man; mean age at surgery 42.5 years). The primary site of metastatic disease was the kidney in five patients (renal cell carcinoma) and the pancreas in one (a pancreatic neuroendocrine tumor). Only one patient had systemic metastases at the time of resection of the hemangioblastoma containing the metastasis. Neurologically, all patients had remained at baseline or were improved at last clinical follow-up examination (mean follow-up duration 16.5 months, range 3-40 months). In all cases, postoperative imaging revealed that the hemangioblastoma resection was complete, and there was no evidence of recurrence in any of the patients at the last follow up. Two patients (including one who was also in the surgical group) were found at autopsy to have CNS metastases exclusively to spinal hemangioblastomas. Conclusions. Hemangioblastomas are an early and preferred site for metastasis in VHL disease. Emerging histopathological techniques may lead to recognition of an increasing number of cases of tumor-to- hemangioblastoma metastasis. Management of cases involving tumor-to- hemangioblastoma metastases in VHL disease should be based on the histological characteristics of the primary tumor, extent of the primary disease, and completeness of the resection.

Original languageEnglish (US)
Pages (from-to)256-263
Number of pages8
JournalJournal of neurosurgery
Volume105
Issue number2
DOIs
StatePublished - Aug 22 2006
Externally publishedYes

Fingerprint

Hemangioblastoma
von Hippel-Lindau Disease
Neoplasm Metastasis
Central Nervous System
Neoplasms
National Institute of Neurological Disorders and Stroke
Autopsy
Hereditary Neoplastic Syndromes
Neuroendocrine Tumors
Kidney Diseases
Case Management
Renal Cell Carcinoma
Pancreas

Keywords

  • Hemangioblastoma
  • Metastasis
  • Tumor-to-tumor metastasis
  • Von Hippel-Lindau disease

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)
  • Clinical Neurology

Cite this

Jarrell, S. T., Vortmeyer, A., Linehan, W. M., Oldfield, E. H., & Lonser, R. R. (2006). Metastases to hemangioblastomas in von Hippel-Lindau disease. Journal of neurosurgery, 105(2), 256-263. https://doi.org/10.3171/jns.2006.105.2.256

Metastases to hemangioblastomas in von Hippel-Lindau disease. / Jarrell, S. Taylor; Vortmeyer, Alexander; Linehan, W. Marston; Oldfield, Edward H.; Lonser, Russell R.

In: Journal of neurosurgery, Vol. 105, No. 2, 22.08.2006, p. 256-263.

Research output: Contribution to journalArticle

Jarrell, ST, Vortmeyer, A, Linehan, WM, Oldfield, EH & Lonser, RR 2006, 'Metastases to hemangioblastomas in von Hippel-Lindau disease', Journal of neurosurgery, vol. 105, no. 2, pp. 256-263. https://doi.org/10.3171/jns.2006.105.2.256
Jarrell, S. Taylor ; Vortmeyer, Alexander ; Linehan, W. Marston ; Oldfield, Edward H. ; Lonser, Russell R. / Metastases to hemangioblastomas in von Hippel-Lindau disease. In: Journal of neurosurgery. 2006 ; Vol. 105, No. 2. pp. 256-263.
@article{ce19eb4dce2b469d9f14a55d8499728a,
title = "Metastases to hemangioblastomas in von Hippel-Lindau disease",
abstract = "Object. Patients with hereditary cancer syndromes may be at increased risk for the development of tumor-to-tumor metastases. To gain insight into the biological nature of these lesions in the central nervous system (CNS), to determine their prevalence in a familial neoplasia syndrome, and to better define their management, the authors retrospectively examined a series of cases in which metastatic lesions developed within hemangioblastomas in patients with von Hippel-Lindau (VHL) disease. Methods. The study included all cases of VHL disease in which patients underwent resection of a CNS hemangioblastoma that contained a metastasis or were found at autopsy to have a metastasis to a hemangioblastoma between January 2002 and December 2005 at the National Institute of Neurological Disorders and Stroke (NINDS). Clinical, histopathological, imaging, and surgical and/or autopsy findings were analyzed. Metastasis to a CNS hemangioblastoma was found in six resected tumors (8{\%} of all hemangioblastomas resected from patients with VHL disease at the NINDS during the study period) from six patients (five women, one man; mean age at surgery 42.5 years). The primary site of metastatic disease was the kidney in five patients (renal cell carcinoma) and the pancreas in one (a pancreatic neuroendocrine tumor). Only one patient had systemic metastases at the time of resection of the hemangioblastoma containing the metastasis. Neurologically, all patients had remained at baseline or were improved at last clinical follow-up examination (mean follow-up duration 16.5 months, range 3-40 months). In all cases, postoperative imaging revealed that the hemangioblastoma resection was complete, and there was no evidence of recurrence in any of the patients at the last follow up. Two patients (including one who was also in the surgical group) were found at autopsy to have CNS metastases exclusively to spinal hemangioblastomas. Conclusions. Hemangioblastomas are an early and preferred site for metastasis in VHL disease. Emerging histopathological techniques may lead to recognition of an increasing number of cases of tumor-to- hemangioblastoma metastasis. Management of cases involving tumor-to- hemangioblastoma metastases in VHL disease should be based on the histological characteristics of the primary tumor, extent of the primary disease, and completeness of the resection.",
keywords = "Hemangioblastoma, Metastasis, Tumor-to-tumor metastasis, Von Hippel-Lindau disease",
author = "Jarrell, {S. Taylor} and Alexander Vortmeyer and Linehan, {W. Marston} and Oldfield, {Edward H.} and Lonser, {Russell R.}",
year = "2006",
month = "8",
day = "22",
doi = "10.3171/jns.2006.105.2.256",
language = "English (US)",
volume = "105",
pages = "256--263",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "2",

}

TY - JOUR

T1 - Metastases to hemangioblastomas in von Hippel-Lindau disease

AU - Jarrell, S. Taylor

AU - Vortmeyer, Alexander

AU - Linehan, W. Marston

AU - Oldfield, Edward H.

AU - Lonser, Russell R.

PY - 2006/8/22

Y1 - 2006/8/22

N2 - Object. Patients with hereditary cancer syndromes may be at increased risk for the development of tumor-to-tumor metastases. To gain insight into the biological nature of these lesions in the central nervous system (CNS), to determine their prevalence in a familial neoplasia syndrome, and to better define their management, the authors retrospectively examined a series of cases in which metastatic lesions developed within hemangioblastomas in patients with von Hippel-Lindau (VHL) disease. Methods. The study included all cases of VHL disease in which patients underwent resection of a CNS hemangioblastoma that contained a metastasis or were found at autopsy to have a metastasis to a hemangioblastoma between January 2002 and December 2005 at the National Institute of Neurological Disorders and Stroke (NINDS). Clinical, histopathological, imaging, and surgical and/or autopsy findings were analyzed. Metastasis to a CNS hemangioblastoma was found in six resected tumors (8% of all hemangioblastomas resected from patients with VHL disease at the NINDS during the study period) from six patients (five women, one man; mean age at surgery 42.5 years). The primary site of metastatic disease was the kidney in five patients (renal cell carcinoma) and the pancreas in one (a pancreatic neuroendocrine tumor). Only one patient had systemic metastases at the time of resection of the hemangioblastoma containing the metastasis. Neurologically, all patients had remained at baseline or were improved at last clinical follow-up examination (mean follow-up duration 16.5 months, range 3-40 months). In all cases, postoperative imaging revealed that the hemangioblastoma resection was complete, and there was no evidence of recurrence in any of the patients at the last follow up. Two patients (including one who was also in the surgical group) were found at autopsy to have CNS metastases exclusively to spinal hemangioblastomas. Conclusions. Hemangioblastomas are an early and preferred site for metastasis in VHL disease. Emerging histopathological techniques may lead to recognition of an increasing number of cases of tumor-to- hemangioblastoma metastasis. Management of cases involving tumor-to- hemangioblastoma metastases in VHL disease should be based on the histological characteristics of the primary tumor, extent of the primary disease, and completeness of the resection.

AB - Object. Patients with hereditary cancer syndromes may be at increased risk for the development of tumor-to-tumor metastases. To gain insight into the biological nature of these lesions in the central nervous system (CNS), to determine their prevalence in a familial neoplasia syndrome, and to better define their management, the authors retrospectively examined a series of cases in which metastatic lesions developed within hemangioblastomas in patients with von Hippel-Lindau (VHL) disease. Methods. The study included all cases of VHL disease in which patients underwent resection of a CNS hemangioblastoma that contained a metastasis or were found at autopsy to have a metastasis to a hemangioblastoma between January 2002 and December 2005 at the National Institute of Neurological Disorders and Stroke (NINDS). Clinical, histopathological, imaging, and surgical and/or autopsy findings were analyzed. Metastasis to a CNS hemangioblastoma was found in six resected tumors (8% of all hemangioblastomas resected from patients with VHL disease at the NINDS during the study period) from six patients (five women, one man; mean age at surgery 42.5 years). The primary site of metastatic disease was the kidney in five patients (renal cell carcinoma) and the pancreas in one (a pancreatic neuroendocrine tumor). Only one patient had systemic metastases at the time of resection of the hemangioblastoma containing the metastasis. Neurologically, all patients had remained at baseline or were improved at last clinical follow-up examination (mean follow-up duration 16.5 months, range 3-40 months). In all cases, postoperative imaging revealed that the hemangioblastoma resection was complete, and there was no evidence of recurrence in any of the patients at the last follow up. Two patients (including one who was also in the surgical group) were found at autopsy to have CNS metastases exclusively to spinal hemangioblastomas. Conclusions. Hemangioblastomas are an early and preferred site for metastasis in VHL disease. Emerging histopathological techniques may lead to recognition of an increasing number of cases of tumor-to- hemangioblastoma metastasis. Management of cases involving tumor-to- hemangioblastoma metastases in VHL disease should be based on the histological characteristics of the primary tumor, extent of the primary disease, and completeness of the resection.

KW - Hemangioblastoma

KW - Metastasis

KW - Tumor-to-tumor metastasis

KW - Von Hippel-Lindau disease

UR - http://www.scopus.com/inward/record.url?scp=33747301220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747301220&partnerID=8YFLogxK

U2 - 10.3171/jns.2006.105.2.256

DO - 10.3171/jns.2006.105.2.256

M3 - Article

C2 - 17219831

AN - SCOPUS:33747301220

VL - 105

SP - 256

EP - 263

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 2

ER -